Hatem Soliman

Testing for Life

Hatem Soliman, 2008 .

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

Amy M. Sitapati, Amy Sitapati, Andres Forero, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay

William Audeh, Pat Whitworth, Hatem Soliman, 2018, JAMA oncology.

Breast cancer version 2.2015: Clinical practice guidelines in oncology

Benjamin O. Anderson, Matthew Philip Goetz, Lee S. Schwartzberg, 2015 .

The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists.

Hatem Soliman, Judy C Boughey, Carol Reynolds, 2011, The oncologist.

NCCN Guidelines Insights: Breast Cancer, Version 3.2018.

Amy M. Sitapati, Amy Sitapati, Chau Dang, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Breast Cancer Version 2.2015.

Andres Forero, Hatem Soliman, Rashmi Kumar, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.